OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Charlotte Teunissen

1 Projects | 1 Researchers | $584,817 Invested

2023

Amsterdam UMC, Universiteit van Amsterdam

Charlotte Teunissen

acTau-174 as a novel biomarker of tau pathology in frontotemporal dementia

  • Funding Amount: $584,817
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Tau
  • Status: Active